更多...
收起
This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
[中文简述(自动翻译):]  此内含子基因编码包含基本的亮氨酸拉链(bZIP蛋白)结构域,并且识别在靶基因的启动子的CCAAT基序的转录因子。在同型二聚体所编码的蛋白质的功能,并与CCAAT /增强子结合蛋白β和γ异二聚体。这种蛋白质的活性可以调节参与细胞周期调控,以及在体重平衡的基因的表达。此基因的突变与急性骨髓性白血病有关。使用替代框内非AUG(GUG)和AUG的开始与不同长度的蛋白异构体密码子的结果。差动翻译起始由一个外的帧,上游开放阅读其位于GUG和第一个AUG起始密码子之间的帧介导的。 [由RefSeq的,2013年12月提供]
CEBPA基因(以及对应的蛋白质)的细胞分布位置:
CEBPA基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Leukemia, Myelocytic, Acute | 0.553105144 | 161 | 11 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_MGD_UNIPROT |
Squamous cell carcinoma | 0.12272435 | 3 | 0 | CTD_human_LHGDN |
Liver carcinoma | 0.122442977 | 11 | 0 | BeFree_CTD_human |
Acute Promyelocytic Leukemia | 0.121357209 | 6 | 0 | BeFree_CTD_human |
Head and Neck Neoplasms | 0.12 | 1 | 0 | CTD_human |
Female infertility | 0.12 | 1 | 0 | CTD_human |
Neoplasms, Radiation-Induced | 0.12 | 1 | 0 | CTD_human |
Precancerous Conditions | 0.12 | 1 | 0 | CTD_human |
Skin Neoplasms | 0.12 | 1 | 0 | CTD_human |
Acute-Phase Reaction | 0.08 | 1 | 0 | RGD |
Transient Ischemic Attack | 0.08 | 1 | 0 | RGD |
Myeloid Leukemia | 0.019750581 | 11 | 0 | BeFree_GAD |
leukemia | 0.010053281 | 28 | 0 | BeFree_LHGDN |
MYELODYSPLASTIC SYNDROME | 0.0089015 | 6 | 0 | BeFree_GAD_LHGDN |
Obesity | 0.006091273 | 6 | 0 | BeFree_GAD |
Lung Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
Mammary Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
Pancreatic Neoplasm | 0.005091382 | 2 | 0 | GAD_LHGDN |
Lymphoma | 0.003538676 | 4 | 0 | BeFree_LHGDN |
Hematologic Neoplasms | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Cytogenetically normal acute myeloid leukemia | 0.003528744 | 13 | 0 | BeFree |
Leukopenia | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Hepatoblastoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Lymphoma, Non-Hodgkin | 0.002909916 | 2 | 0 | BeFree_GAD |
Multiple Myeloma | 0.002909916 | 2 | 0 | BeFree_GAD |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.00272435 | 1 | 0 | LHGDN |
Hyperlipidemia | 0.002638474 | 1 | 0 | BeFree_GAD |
Metabolic Syndrome X | 0.002638474 | 2 | 0 | BeFree_GAD |
Leukemogenesis | 0.002442977 | 9 | 0 | BeFree |
Alzheimer's Disease | 0.002367032 | 1 | 0 | GAD |
Chromosome Aberrations | 0.002367032 | 1 | 0 | GAD |
Peripheral Vascular Diseases | 0.002367032 | 1 | 0 | GAD |
Myocardial Ischemia | 0.002367032 | 1 | 0 | GAD |
Liver neoplasms | 0.001085767 | 4 | 0 | BeFree |
Preleukemia | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of lung | 0.001085767 | 4 | 0 | BeFree |
Carcinoma of lung | 0.001085767 | 4 | 0 | BeFree |
Myeloproliferative disease | 0.000814326 | 3 | 0 | BeFree |
Acute leukemia | 0.000814326 | 3 | 0 | BeFree |
Adult Acute Myeloblastic Leukemia | 0.000814326 | 3 | 0 | BeFree |
pediatric acute myeloblastic leukemia | 0.000814326 | 3 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of liver | 0.000814326 | 3 | 0 | BeFree |
Non-alcoholic Fatty Liver Disease | 0.000814326 | 3 | 0 | BeFree |
Carcinogenesis | 0.000814326 | 3 | 0 | BeFree |
Myeloid neoplasm | 0.000814326 | 3 | 0 | BeFree |
Carcinoma, Transitional Cell | 0.000542884 | 2 | 0 | BeFree |
Congenital chromosomal disease | 0.000542884 | 2 | 0 | BeFree |
Fatty Liver | 0.000542884 | 2 | 0 | BeFree |
Neuroblastoma | 0.000542884 | 2 | 0 | BeFree |
Lymphoma, Large-Cell, Follicular | 0.000542884 | 2 | 0 | BeFree |
Liposarcoma, Dedifferentiated | 0.000542884 | 2 | 0 | BeFree |
Central neuroblastoma | 0.000542884 | 2 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Urothelial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Blood Platelet Disorders | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of breast | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of skin | 0.000271442 | 1 | 0 | BeFree |
Cardiovascular Diseases | 0.000271442 | 1 | 0 | BeFree |
Malignant tumor of cervix | 0.000271442 | 1 | 0 | BeFree |
Diabetes Mellitus | 0.000271442 | 1 | 0 | BeFree |
Diabetes Mellitus, Non-Insulin-Dependent | 0.000271442 | 1 | 0 | BeFree |
Hypoglycemia | 0.000271442 | 1 | 0 | BeFree |
Lymphoid leukemia | 0.000271442 | 1 | 0 | BeFree |
Myeloid Leukemia, Chronic | 0.000271442 | 1 | 0 | BeFree |
Acute myelomonocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
Monosomy | 0.000271442 | 1 | 0 | BeFree |
Acute Myeloid Leukemia, M1 | 0.000271442 | 1 | 0 | BeFree |
Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Kaposi Sarcoma | 0.000271442 | 1 | 0 | BeFree |
B-Cell Lymphomas | 0.000271442 | 1 | 0 | BeFree |
Diffuse Large B-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of unknown primary | 0.000271442 | 1 | 0 | BeFree |
Pancreatic carcinoma | 0.000271442 | 1 | 0 | BeFree |
Chronic cervicitis | 0.000271442 | 1 | 0 | BeFree |
Cervical Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Acute Undifferentiated Leukemia | 0.000271442 | 1 | 0 | BeFree |
Cervix carcinoma | 0.000271442 | 1 | 0 | BeFree |
Obesity, Abdominal | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of prostate | 0.000271442 | 1 | 0 | BeFree |
Osteosarcoma of bone | 0.000271442 | 1 | 0 | BeFree |
Tumor Initiation | 0.000271442 | 1 | 0 | BeFree |
Prostate carcinoma | 0.000271442 | 1 | 0 | BeFree |
Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of the head and neck | 0.000271442 | 1 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.000271442 | 1 | 0 | BeFree |
Chronic myeloproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
Mature B-Cell Non-Hodgkin Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Undifferentiated leukemia | 0.000271442 | 1 | 0 | BeFree |
Hepatocarcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Skin Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
MYELOID TUMOR SUPPRESSOR | 0.000271442 | 1 | 0 | BeFree |
Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
Familial Acute Myeloid Leukemia with Mutated Cebpa | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。